Profounda receives USPTO Trademark Approval

Profounda receives approval from the USPTO for 2 new trademarks and design for Profounda logo

Patient survives Brain Eating Amoeba

Profounda OutLicenses right to development product

Company formation complete

Here we come 2023!

Generic to Arestin Microspheres by Bausch Health (Orapharma) receives Competitive Generic Therapy De

DOG AND HUMANS GET GREAT RESULTS

Sales exceed $2 Million for first year of Profounda's Commercial Presence in the USA

Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine

PROFOUNDA, INC.